Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants

Inclusion Criteria: * Be capable of and willing to comply with study restrictions and procedures * Female participants must be non-nursing, have a negative pregnancy test result at screening and Day -1, and be surgically sterile for at least 90 days prior to screening or postmenopausal * Male participants with female partners of child bearing potential must agree to use 2 acceptable forms of birth control for the duration of the study and for 90 days following the last administration of the drug; all male participants must refrain from donating sperm for this same period * Be considered healthy by the Investigator, based on participant's reported medical history, full physical examination, clinical laboratory tests, 12-lead electrocardiograms (ECG) and vital signs * Have normal renal function as determined by Investigator * Have a body mass index (BMI) of 18.0 to 30.0 kg/m\^2 inclusive and body weight \>50.0 kg at screening * Have no relevant dietary restrictions * Be willing to comply with COVID-19 policy Exclusion Criteria: * Clinically significant history of gastrointestinal, cardiovascular, musculoskeletal, endocrine, hematologic, renal, hepatic, bronchopulmonary, psychiatric, neurologic, immunologic or lipid metabolism disorders, or drug hypersensitivity as determined by the Investigator * Known or suspected malignancy * History of pancreatitis or gall stones * History of unexplained syncope, symptomatic hypotension, or hypoglycemia * Personal or family history of lon…